Insulin glargine superior long-term therapy in type 2 DM in Europe Meeting report 30 January 2013 Pages: 3 - 4
US CMS recommendation to increase generic drug use welcomed Media release 30 January 2013 Pages: 4 - 4
Ensuring the quality of QOL instruments for use in clinical trials Comment 30 January 2013 Pages: 5 - 5
Ciprofloxacin/dexamethasone worth it for paediatric acute otitis media Clinical study 30 January 2013 Pages: 6 - 6
Infliximab cost effective for ankylosing spondylitis in the UK Clinical study 30 January 2013 Pages: 7 - 7
Preventing GI complications only cost effective in patients at risk Clinical study 30 January 2013 Pages: 7 - 7
US formulary inclusion more likely if drug's value established Media release 30 January 2013 Pages: 7 - 7
Drug benefits for US elderly should cover wide range of drugs in class News item 30 January 2013 Pages: 9 - 9
Antihistamine benefits substantial but costs of sedation even higher Clinical study 30 January 2013 Pages: 10 - 10
COX-2s preferred over nonselective NSAIDs in coumarin recipients Clinical study 30 January 2013 Pages: 10 - 10
Lower IOP correlates with stable disease, lower treatment costs Clinical study 30 January 2013 Pages: 10 - 10
Pfizer's amlodipine leads half-year prescriptions in Japanese market News item 30 January 2013 Pages: 11 - 11
Prices of essential drugs to be drastically cut in the Philippines News item 30 January 2013 Pages: 11 - 11